2007
DOI: 10.1016/j.ntt.2007.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Oral treatment with ACCUTANE® does not increase measures of anhedonia or depression in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 72 publications
1
10
0
Order By: Relevance
“…22 These changes were not seen in adult rats. 27 In 13 humans, isotretinoin decreased orbitofrontal cortex metabolism, but this decrease was not accompanied by an increase in the severity of depression. 28 Limitations and strengths of study Our study has some limitations.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…22 These changes were not seen in adult rats. 27 In 13 humans, isotretinoin decreased orbitofrontal cortex metabolism, but this decrease was not accompanied by an increase in the severity of depression. 28 Limitations and strengths of study Our study has some limitations.…”
Section: Discussionmentioning
confidence: 98%
“…This indicates that they Several studies have shown that the molecular components needed for retinoic acid signalling are expressed in the adult brain, suggesting that retinoids could play a role in affective disorders. [21][22][23][24][25][26][27][28][29] In young adult mice, chronic administration of isotretinoin induced depression related behaviours. 22 These changes were not seen in adult rats.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, treatment of rats with RA also leads to degradation in performance in learning and memory tests (Dopheide and Morgan 2008) while others have reported an increase in anxiety like behaviour (Cai et al 2010). Despite these multiple effects by RA on the CNS, its influence on depression-like behaviour in the rodent is less clear with several studies pointing to an increase in some depressive-like behaviours (O’Reilly et al 2006; Trent et al 2009) with others studies showing no change (Ferguson et al 2005, 2007). One possible explanation for variation in result between studies is the baseline of RA signalling—RA exhibits a U-shaped curve in its toxicity, with detrimental effects in both deficiency and excess and endogenous levels crucially influence the possible harmful effect of an exogenous dose.…”
Section: Discussionmentioning
confidence: 99%
“…Controversially, the use of 13- cis -RA has been reported to increase the incidence of depressive illness in approximately 1-10% of patients receiving the drug (Hull and D’Arcy, 2005, Bremner and McCaffery, 2008). In animal studies chronic administration of 1 mg/kg 13- cis -RA has been shown to increase depression-related behaviours in both mice and rats (O’Reilly et al, 2006, Trent et al, 2009) but not in all studies of the adult rat (Ferguson et al, 2005, 2007). However, the mechanism by which 13- cis -RA treatment can influence depression-related behavioural changes remains poorly understood.…”
Section: Introductionmentioning
confidence: 94%